Informação sobre produto
SR9238 is a drug that is being developed for the treatment of hepatic steatosis, which is a condition characterized by excessive fat accumulation in the liver. It has been shown to reduce plasma glucose levels, fatty acid synthesis, and cholesterol synthesis in animal models. SR9238 also shows promising effects on insulin resistance, which is a condition that leads to diabetes. This drug has been shown to inhibit site-specific chemical reactions in cells, such as the biosynthesis of phospholipids and triglycerides. SR9238 has also been shown to increase cancer cell viability in cell culture studies and reduce atherosclerotic lesion size in mouse models.
Propriedades químicas
Consulta técnica sobre: 3D-RGC15362 SR9238
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
